Fasting enhances the response of glioma to chemo- and radiotherapy.
Glioma, including anaplastic astrocytoma and glioblastoma multiforme (GBM) are among the most commonly diagnosed malignant adult brain tumors. GBM is a highly invasive and angiogenic tumor, resulting in a 12 to 15 months median survival. The treatment of GBM is multimodal and includes surgical resec...
Main Authors: | Fernando Safdie, Sebastian Brandhorst, Min Wei, Weijun Wang, Changhan Lee, Saewon Hwang, Peter S Conti, Thomas C Chen, Valter D Longo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3439413?pdf=render |
Similar Items
-
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
by: Li Hu, et al.
Published: (2021-05-01) -
Correction: Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy.
by: Stefano Di Biase, et al.
Published: (2017-05-01) -
Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy
by: Jac A. Nickoloff
Published: (2022-07-01) -
Exploring juventology: unlocking the secrets of youthspan and longevity programs
by: Sebastian Brandhorst, et al.
Published: (2024-04-01) -
Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
by: Barbara Castelli, et al.
Published: (2023-09-01)